A detailed history of Citigroup Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Citigroup Inc holds 752,426 shares of LLY stock, worth $599 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
752,426
Previous 774,634 2.87%
Holding current value
$599 Million
Previous $701 Million 4.95%
% of portfolio
0.39%
Previous 0.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $17.1 Million - $21.3 Million
-22,208 Reduced 2.87%
752,426 $667 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $115 Million - $144 Million
158,051 Added 25.63%
774,634 $701 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $19.8 Million - $26.5 Million
33,482 Added 5.74%
616,583 $480 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $40.3 Million - $47.6 Million
-76,807 Reduced 11.64%
583,101 $340 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $13.6 Million - $18.7 Million
-31,213 Reduced 4.52%
659,908 $354 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $22.5 Million - $30.1 Million
-64,176 Reduced 8.5%
691,121 $324 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $24.4 Million - $28.6 Million
-78,531 Reduced 9.42%
755,297 $259 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $55.4 Million - $64.5 Million
-172,203 Reduced 17.12%
833,828 $305 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $81.4 Million - $92.7 Million
274,428 Added 37.51%
1,006,031 $325 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $16.4 Million - $19.2 Million
-58,818 Reduced 7.44%
731,603 $237 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $6.5 Million - $8.08 Million
27,710 Added 3.63%
790,421 $226 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $9.66 Million - $12 Million
-42,941 Reduced 5.33%
762,711 $211 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $179 Million - $220 Million
805,652 New
805,652 $186 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.